Healthcare & Medical Devices Global On demand · 24-48h

Global Cardiac Loop Recorder Market Strategic Research Report

Global Cardiac Loop Recorder Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Cardiac Loop Recorder Market
$1.57B2025
8.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Smartphone Compatible, Smartphone Incompatible

By Application: Hospitals, Ambulatory Surgical Centers (ASCs), Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Medtronic, Abbott, Boston Scientific, BIOTRONIK, GE HealthCare, Philips, Baxter, Spacelabs Healthcare, Bittium, SCHILLER, GETEMED, Vitaphone, Norav Medical, AliveCor, Lepu Medical, Nalong Health, Contec Medical, Borsam Biomedical, Fukuda Denshi, Nihon Kohden, Suzuken

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 163 pages
Market size 2025
$1.57B
Billion USD
Forecast CAGR
8.8%
2025-2032
Forecast 2032
$2.8B
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Cardiac Loop Recorder market size is predicted to grow from US$ 1,566 million in 2025 to US$ 2,821 million in 2032; it is expected to grow at a CAGR of 8.8% from 2026 to 2032.

Cardiac loop recorders—typically referred to as cardiac event recorders or cardiac loop recorders—are medical devices designed for the long-term monitoring and recording of electrocardiographic (ECG) signals. Their primary purpose is to detect transient, intermittent, or elusive cardiac arrhythmias that are difficult to capture via standard ECGs. These devices function by continuously capturing the heart's electrical activity; specifically, when a patient experiences symptoms such as palpitations, syncope, or chest tightness—or when the device automatically detects an abnormal rhythm—it saves a segment of ECG data spanning the period immediately before and after the event. This data assists physicians in diagnosing conditions such as atrial fibrillation, tachycardia, bradycardia, and conduction blocks. Based on their method of use, these devices can be categorized into external (wearable) event recorders and implantable loop recorders. Among these, implantable devices are designed for long-term subcutaneous monitoring—spanning anywhere from several months to several years—and are frequently utilized in clinical scenarios involving unexplained syncope, occult atrial fibrillation, and post-stroke cardiac rhythm monitoring.

The upstream segment of the cardiac loop recorder industry chain primarily encompasses components and technologies such as ECG acquisition chips, low-power MCUs, memory chips, batteries, Bluetooth/cellular communication modules, medical-grade electrodes, implantable casing materials, packaging materials, algorithmic software, and cloud-based data platforms. The midstream segment consists of manufacturers specializing in external event recorders, Holter monitors, and implantable loop recorders (also known as insertable cardiac monitors). The downstream segment primarily comprises end-users and payers, including hospital cardiology departments, electrophysiology centers, stroke centers, medical examination facilities, remote ECG monitoring service providers, and medical insurance/commercial insurance payers. The gross margin for cardiac loop recorders typically stands at approximately 51%.

In 2025, the average unit price for cardiac loop recorders is projected to be $5,000; sales volume is expected to reach 320.2 k units, while total production capacity is estimated at 457.4 k units.

The growing demand for cardiac loop recorders is primarily driven by the need for long-term heart rhythm monitoring and early risk identification. Conventional ECGs and short-term Holter monitoring often struggle to capture intermittent and transient arrhythmias; however, cardiac loop recorders enable extended periods of continuous or event-triggered monitoring, thereby offering significant clinical value in cases of unexplained syncope, occult atrial fibrillation, post-stroke rhythm screening, palpitation assessment, and the follow-up care of high-risk cardiovascular patients. Amidst an aging population, rising prevalence of atrial fibrillation, and the widespread adoption of telemedicine, the demand from both hospitals and patients for long-term, low-burden, and remotely transmissible ECG monitoring devices is expected to continue its upward trajectory.

The focal point of industry competition is shifting from mere hardware recording capabilities toward a comprehensive suite of capabilities encompassing "device + algorithms + remote monitoring platforms." While early cardiac loop recorders primarily emphasized recording duration, signal quality, and event storage capacity, the current market places greater emphasis on the accuracy of algorithms for automatically detecting abnormal rhythms—such as atrial fibrillation, tachycardia, bradycardia, and pauses—as well as the completeness of integrated systems covering data uploading, physician workstations, report generation, and patient management platforms. For manufacturers, implantable devices face high barriers to entry regarding regulatory registration, clinical evidence requirements, insurance reimbursement, and hospital distribution channels; conversely, external wearable devices operate in a more fully competitive landscape characterized by greater price pressure, necessitating differentiation through superior comfort, battery life, cloud platform integration, and AI-driven analytical capabilities.

In the future, cardiac loop recorders are poised to evolve toward greater miniaturization, intelligence, remote accessibility, and continuous management capabilities. Implantable loop recorders will continue to improve battery life, minimize procedural invasiveness, enhance diagnostic accuracy through automation, and integrate deeply with remote patient follow-up systems; meanwhile, external recorders will expand into lightweight patch-based devices, general wearables, and home-based monitoring applications. From a long-term perspective, the true value of this industry lies not merely in "recording ECG data," but in empowering physicians to detect high-risk arrhythmias at an earlier stage, minimize missed diagnoses, optimize treatment decisions, and—through remote monitoring—reduce the costs associated with repetitive clinic visits and hospital admissions for patients.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiac Loop Recorder market?

What factors are driving Cardiac Loop Recorder market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiac Loop Recorder market opportunities vary by end market size?

How does Cardiac Loop Recorder break out by Type, by Application?

This report presents a comprehensive overview of the global Cardiac Loop Recorder market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Smartphone Compatible
  • Smartphone Incompatible

Segment by Number of Channels

  • Single-Lead Type (1-Channel)
  • Multi-Lead Type (2–12 Leads)

Segment by Implantation Method

  • External Loop Recorder
  • Implantable Loop Recorder

Segment by Application

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cardiac Loop Recorder market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Ambulatory Surgical Centers (ASCs), Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Cardiac Loop Recorder Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.57B
2025
Forecast
$2.8B
2032
CAGR
8.8%
2025–2032
영역들
5
global
Key companies
MedtronicAbbottBoston ScientificBIOTRONIKGE HealthCarePhilipsBaxterSpacelabs Healthcare
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Smartphone CompatibleSmartphone Incompatible
By Application
HospitalsAmbulatory Surgical Centers (ASCs)Other

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Smartphone Compatible
  • 3.1.3 Smartphone Incompatible
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Ambulatory Surgical Centers (ASCs)
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Medtronic
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Abbott
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Boston Scientific
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 BIOTRONIK
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 GE HealthCare
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Philips
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Baxter
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Spacelabs Healthcare
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Bittium
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 SCHILLER
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 GETEMED
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Vitaphone
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Norav Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 AliveCor
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Lepu Medical
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Nalong Health
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Contec Medical
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Borsam Biomedical
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Fukuda Denshi
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Nihon Kohden
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Suzuken
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Cardiac Loop Recorder market size?
The global Cardiac Loop Recorder market is estimated at US$ 1.57 billion in 2025 (base year) and is projected to reach US$ 2.82 billion by 2032.
What growth rate is expected for the Cardiac Loop Recorder market through 2032?
The market is expected to grow at a CAGR of 8.8% from 2026 to 2032, expanding from US$ 1.57 billion in 2025 to US$ 2.82 billion in 2032, roughly 1.8 times its base-year value.
How is Cardiac Loop Recorder defined?
Cardiac loop recorders—typically referred to as cardiac event recorders or cardiac loop recorders—are medical devices designed for the long-term monitoring and recording of electrocardiographic (ECG) signals. Their primary purpose is to detect transient, intermittent, or elusive cardiac arrhythmias that are difficult to capture via standard ECGs.
What are the main segments of the Cardiac Loop Recorder market by type?
By type, the market is segmented into Smartphone Compatible and Smartphone Incompatible.
Which applications drive demand in the Cardiac Loop Recorder market?
Key applications covered include Hospitals, Ambulatory Surgical Centers (ASCs) and Other.
Who are the key players in the Cardiac Loop Recorder market?
Key players profiled include Medtronic, Abbott, Boston Scientific, BIOTRONIK, GE HealthCare, Philips, Baxter and Spacelabs Healthcare, among 21 companies covered in total.
Which regions and countries are covered for Cardiac Loop Recorder?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Cardiac Loop Recorder market?
The growing demand for cardiac loop recorders is primarily driven by the need for long-term heart rhythm monitoring and early risk identification.
Who should buy the Cardiac Loop Recorder market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Ambulatory Surgical Centers (ASCs) and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Cardiac Loop Recorder market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.